Compromised Protein Prenylation as Pathogenic Mechanism in Mevalonate Kinase Deficiency
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Compromised Protein Prenylation as Pathogenic Mechanism in Mevalonate Kinase Deficiency
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 12, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-09-04
DOI
10.3389/fimmu.2021.724991
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Dietary Geranylgeranyl Pyrophosphate Counteracts the Benefits of Statin Therapy in Experimental Pulmonary Hypertension
- (2021) Liping Zhu et al. CIRCULATION
- IL-1 Inhibitors in the Treatment of Monogenic Periodic Fever Syndromes: From the Past to the Future Perspectives
- (2021) Hana Malcova et al. Frontiers in Immunology
- Mevalonate Kinase-Associated Diseases: Hunting for Phenotype–Genotype Correlation
- (2021) Guilaine Boursier et al. Journal of Clinical Medicine
- A toxicological evaluation of geranylgeraniol
- (2021) Kayla Preece et al. REGULATORY TOXICOLOGY AND PHARMACOLOGY
- Effects of mevalonate kinase interference on cell differentiation, apoptosis, prenylation and geranylgeranylation of human keratinocytes are attenuated by farnesyl pyrophosphate or geranylgeranyl pyrophosphate
- (2020) Min Li et al. Experimental and Therapeutic Medicine
- Oxysterols: From physiological tuners to pharmacological opportunities
- (2020) Andrew J. Brown et al. BRITISH JOURNAL OF PHARMACOLOGY
- A toxic palmitoylation of Cdc42 enhances NF-κB signaling and drives a severe autoinflammatory syndrome
- (2020) Bahia Bekhouche et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Cholesterol metabolism drives regulatory B cell IL-10 through provision of geranylgeranyl pyrophosphate
- (2020) Jack A. Bibby et al. Nature Communications
- Management of Mevalonate Kinase Deficiency: A Pediatric Perspective
- (2020) Jerold Jeyaratnam et al. Frontiers in Immunology
- Current Therapeutic Options for the Main Monogenic Autoinflammatory Diseases and PFAPA Syndrome: Evidence-Based Approach and Proposal of a Practical Guide
- (2020) Alessandra Soriano et al. Frontiers in Immunology
- HAPLOIDENTICAL α/β T-CELL AND B-CELL STEM CELL TRANSPLANTATION IN SEVERE MEVALONATE KINASE DEFICIENCY
- (2020) Maura Faraci et al. RHEUMATOLOGY
- The cholesterol biosynthesis pathway regulates IL-10 expression in human Th1 cells
- (2019) Esperanza Perucha et al. Nature Communications
- Lack of protein prenylation promotes NLRP3 inflammasome assembly in human monocytes
- (2019) Oliver P. Skinner et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- IL-10 Family Cytokines IL-10 and IL-22: from Basic Science to Clinical Translation
- (2019) Wenjun Ouyang et al. IMMUNITY
- Severe autoinflammation in 4 patients with C-terminal variants in cell division control protein 42 homolog (CDC42) successfully treated with IL-1β inhibition
- (2019) Yael Gernez et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Clonal expansion of second-hit cells with somatic recombinations or C>T transitions form porokeratosis in MVD or MVK mutant heterozygotes
- (2019) Akiharu Kubo et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Endogenous sterol intermediates of the mevalonate pathway regulate HMGCR degradation and SREBP-2 processing
- (2019) Liang Chen et al. JOURNAL OF LIPID RESEARCH
- The Pyrin Inflammasome in Health and Disease
- (2019) Oskar Schnappauf et al. Frontiers in Immunology
- Defective Protein Prenylation in a Spectrum of Patients With Mevalonate Kinase Deficiency
- (2019) Marcia A. Munoz et al. Frontiers in Immunology
- A novel disorder involving dyshematopoiesis, inflammation, and HLH due to aberrant CDC42 function
- (2019) Michael T. Lam et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Mevalonic aciduria: Does stem cell transplant fully cure disease?
- (2019) Ann Marie Szymanski et al. PEDIATRIC TRANSPLANTATION
- Protein prenylation restrains innate immunity by inhibiting Rac1 effector interactions
- (2019) Murali K. Akula et al. Nature Communications
- Pharmacological Inhibitors of the NLRP3 Inflammasome
- (2019) Ayesha Zahid et al. Frontiers in Immunology
- Mechanisms and regulation of cholesterol homeostasis
- (2019) Jie Luo et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Functional Dysregulation of CDC42 Causes Diverse Developmental Phenotypes
- (2018) Simone Martinelli et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Retrospective on Cholesterol Homeostasis: The Central Role of Scap
- (2018) Michael S. Brown et al. Annual Review of Biochemistry
- Metabolic Induction of Trained Immunity through the Mevalonate Pathway
- (2018) Siroon Bekkering et al. CELL
- Repositioning of Tak-475 In Mevalonate Kinase Disease: Translating Theory Into Practice
- (2018) Annalisa Marcuzzi et al. CURRENT MEDICINAL CHEMISTRY
- Mutations in mevalonate pathway genes in patients with familial or sporadic porokeratosis
- (2018) Yunji Leng et al. JOURNAL OF DERMATOLOGY
- Efficacy of Continuous Interleukin 1 Blockade in Mevalonate Kinase Deficiency: A Multicenter Retrospective Study in 13 Adult Patients and Literature Review
- (2018) Samuel Deshayes et al. JOURNAL OF RHEUMATOLOGY
- Canakinumab for the Treatment of Autoinflammatory Recurrent Fever Syndromes
- (2018) Fabrizio De Benedetti et al. NEW ENGLAND JOURNAL OF MEDICINE
- Non-syndromic retinitis pigmentosa
- (2018) Sanne K. Verbakel et al. PROGRESS IN RETINAL AND EYE RESEARCH
- 25-Hydroxycholesterol and inflammation in Lovastatin-deregulated mevalonate pathway
- (2017) Paola Maura Tricarico et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Mevalonate kinase deficiency associated with ataxia and retinitis pigmentosa in two brothers with MVK gene mutations
- (2017) Ulrich Kellner et al. OPHTHALMIC GENETICS
- International Retrospective Chart Review of Treatment Patterns in Severe Familial Mediterranean Fever, Tumor Necrosis Factor Receptor-Associated Periodic Syndrome, and Mevalonate Kinase Deficiency/Hyperimmunoglobulinemia D Syndrome
- (2017) Seza Ozen et al. ARTHRITIS CARE & RESEARCH
- Rab GTPases in Immunity and Inflammation
- (2017) Akriti Prashar et al. Frontiers in Cellular and Infection Microbiology
- Open-Label, Phase II Study to Assess the Efficacy and Safety of Canakinumab Treatment in Active Hyperimmunoglobulinemia D With Periodic Fever Syndrome
- (2017) Juan I. Arostegui et al. Arthritis & Rheumatology
- Canakinumab reverses overexpression of inflammatory response genes in tumour necrosis factor receptor-associated periodic syndrome
- (2016) Rebecca Torene et al. ANNALS OF THE RHEUMATIC DISEASES
- Mevalonate kinase deficiency leads to decreased prenylation of Rab GTPases
- (2016) Julie Jurczyluk et al. IMMUNOLOGY AND CELL BIOLOGY
- Geranylgeranyl-regulated transport of the prenyltransferase UBIAD1 between membranes of the ER and Golgi
- (2016) Marc M. Schumacher et al. JOURNAL OF LIPID RESEARCH
- Mutations in the mevalonate pathway genes in Chinese patients with porokeratosis
- (2016) M. Li et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Control of the innate immune response by the mevalonate pathway
- (2016) Murali K Akula et al. NATURE IMMUNOLOGY
- Pyrin inflammasome activation and RhoA signaling in the autoinflammatory diseases FMF and HIDS
- (2016) Yong Hwan Park et al. NATURE IMMUNOLOGY
- Protein prenylation: unique fats make their mark on biology
- (2016) Mei Wang et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Regulating Rho GTPases and their regulators
- (2016) Richard G. Hodge et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Massive ascites in a canakinumab resistant case with MVA leading to bone marrow transplantation
- (2016) Sahin Erdol et al. RHEUMATOLOGY INTERNATIONAL
- The Phenotype and Genotype of Mevalonate Kinase Deficiency: A Series of 114 Cases From the Eurofever Registry
- (2016) Nienke M. ter Haar et al. Arthritis & Rheumatology
- Anti-inflammatory and cytoprotective effects of a squalene synthase inhibitor, TAK-475 active metabolite-I, in immune cells simulating mevalonate kinase deficiency (MKD)-like condition
- (2016) Nobutaka Suzuki et al. SpringerPlus
- Mevalonate Pathway Blockade, Mitochondrial Dysfunction and Autophagy: A Possible Link
- (2015) Paola Tricarico et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Knockdown of MVK does not lead to changes in NALP3 expression or activation
- (2015) Fulvio Celsi et al. Journal of Inflammation-London
- Mitochondria in autoinflammation: cause, mediator or bystander?
- (2015) Robert van der Burgh et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Genomic variations of the mevalonate pathway in porokeratosis
- (2015) Zhenghua Zhang et al. eLife
- Interleukin 6 Blockade for Hyperimmunoglobulin D and Periodic Fever Syndrome
- (2015) Hiba M. Shendi et al. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY
- Mevalonate kinase deficiency and IBD: shared genetic background
- (2014) Anna Monica Bianco et al. GUT
- Unprenylated RhoA Contributes to IL-1β Hypersecretion in Mevalonate Kinase Deficiency Model through Stimulation of Rac1 Activity
- (2014) Robert van der Burgh et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Exome sequencing identifiesSLC17A9pathogenic gene in two Chinese pedigrees with disseminated superficial actinic porokeratosis
- (2014) Hongzhou Cui et al. JOURNAL OF MEDICAL GENETICS
- Innate immune sensing of bacterial modifications of Rho GTPases by the Pyrin inflammasome
- (2014) Hao Xu et al. NATURE
- Long-term Outcome of a Successful Cord Blood Stem Cell Transplant in Mevalonate Kinase Deficiency
- (2014) S. Giardino et al. PEDIATRICS
- TLR2/TLR4-dependent exaggerated cytokine production in hyperimmunoglobulinaemia D and periodic fever syndrome
- (2014) Monique Stoffels et al. RHEUMATOLOGY
- 25-Hydroxycholesterol suppresses interleukin-1-driven inflammation downstream of type I interferon
- (2014) A. Reboldi et al. SCIENCE
- Monogenic diseases associated with intestinal inflammation: implications for the understanding of inflammatory bowel disease
- (2013) Holm H Uhlig GUT
- Defects in Mitochondrial Clearance Predispose Human Monocytes to Interleukin-1β Hypersecretion
- (2013) Robert van der Burgh et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Mutations in the Mevalonate Kinase ( MVK ) Gene Cause Nonsyndromic Retinitis Pigmentosa
- (2013) Anna M. Siemiatkowska et al. OPHTHALMOLOGY
- Liver Transplantation Followed by Allogeneic Hematopoietic Stem Cell Transplantation for Atypical Mevalonic Aciduria
- (2012) S. Chaudhury et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Treatment of autoinflammatory diseases: results from the Eurofever Registry and a literature review
- (2012) Nienke ter Haar et al. ANNALS OF THE RHEUMATIC DISEASES
- Mevalonate kinase deficiency, a metabolic autoinflammatory disease
- (2012) Robert van der Burgh et al. CLINICAL IMMUNOLOGY
- Exome sequencing identifies MVK mutations in disseminated superficial actinic porokeratosis
- (2012) Sheng-Quan Zhang et al. NATURE GENETICS
- Efficacy of interleukin-1-targeting drugs in mevalonate kinase deficiency
- (2012) C. Galeotti et al. RHEUMATOLOGY
- Lapaquistat Acetate
- (2011) Evan A. Stein et al. CIRCULATION
- Geranylgeranyltransferase type I (GGTase-I) deficiency hyperactivates macrophages and induces erosive arthritis in mice
- (2011) Omar M. Khan et al. JOURNAL OF CLINICAL INVESTIGATION
- Mevalonate Kinase Deficiency: A Survey of 50 Patients
- (2011) B. Bader-Meunier et al. PEDIATRICS
- Autoinflammatory Disease Reloaded: A Clinical Perspective
- (2010) Daniel L. Kastner et al. CELL
- The inhibition of mevalonate pathway induces upregulation of NALP3 expression: new insight in the pathogenesis of mevalonate kinase deficiency
- (2010) Alessandra Pontillo et al. EUROPEAN JOURNAL OF HUMAN GENETICS
- Compromized geranylgeranylation of RhoA and Rac1 in mevalonate kinase deficiency
- (2010) L. Henneman et al. JOURNAL OF INHERITED METABOLIC DISEASE
- Coenzyme Q10 is decreased in fibroblasts of patients with methylmalonic aciduria but not in mevalonic aciduria
- (2009) D. Haas et al. JOURNAL OF INHERITED METABOLIC DISEASE
- HMG-CoA reductase inhibition induces IL-1 release through Rac1/PI3K/PKB-dependent caspase-1 activation
- (2008) L. M. Kuijk et al. BLOOD
- Long-Term Follow-Up, Clinical Features, and Quality of Life in a Series of 103 Patients With Hyperimmunoglobulinemia D Syndrome
- (2008) Jeroen C. H. van der Hilst et al. MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started